These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 33223557)
1. A comparison of SARS-CoV-2 antibody assays evaluated in Auckland, New Zealand. Fox-Lewis S; Whitcombe A; McGregor R; Carlton L; Hwang Y; Austin P; Aspin L; Raill B; Webb R; Taylor S; Morpeth S; Roberts S; Moreland NJ; McAuliffe G N Z Med J; 2020 Nov; 133(1525):127-131. PubMed ID: 33223557 [No Abstract] [Full Text] [Related]
2. Correlation of SARS-CoV-2 Neutralizing Antibodies to an Automated Chemiluminescent Serological Immunoassay. Grenache DG; Ye C; Bradfute SB J Appl Lab Med; 2021 Mar; 6(2):491-495. PubMed ID: 33098417 [TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of four rapid SARS-CoV-2 antigen detection tests using universal transport medium. Weitzel T; Legarraga P; Iruretagoyena M; Pizarro G; Vollrath V; Araos R; Munita JM; Porte L Travel Med Infect Dis; 2021; 39():101942. PubMed ID: 33278609 [No Abstract] [Full Text] [Related]
4. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations. Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera. Perera RAPM; Ko R; Tsang OTY; Hui DSC; Kwan MYM; Brackman CJ; To EMW; Yen HL; Leung K; Cheng SMS; Chan KH; Chan KCK; Li KC; Saif L; Barrs VR; Wu JT; Sit THC; Poon LLM; Peiris M J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139421 [TBL] [Abstract][Full Text] [Related]
6. Clinical performance of the Advia Centaur anti-SARS-CoV-2 chemiluminescent immunoassay related to antibody kinetics. Ocmant A; Roisin S; De Meuter R; Brauner J J Med Virol; 2021 May; 93(5):2583-2584. PubMed ID: 33448403 [No Abstract] [Full Text] [Related]
7. SARS-CoV-2-specific IgM screening has low sensitivity for identifying potentially infectious travellers. Hasan T; Lim HL; Hueston L; Dwyer DE; O'Sullivan M Pathology; 2021 Dec; 53(7):917-919. PubMed ID: 34635322 [No Abstract] [Full Text] [Related]
8. SARS-CoV-2 infection serology validation of different methods: Usefulness of IgA in the early phase of infection. Pieri M; Ciotti M; Carlozzi N; Frassanito ML; Meloni A; Cistera A; Turchetti G; Niscola S; Labate G; Calugi G; Bernardini S Clin Chim Acta; 2020 Dec; 511():28-32. PubMed ID: 33002475 [TBL] [Abstract][Full Text] [Related]
9. Usefulness and limitations of implementing rapid tests for the diagnosis of COVID-19 in Latin America. García-Díaz G; Montalvo-Varela E; Cano-Pérez E; da Silva Francisco Junior R; Rodriguez-Morales A Infez Med; 2020 Dec; 28(4):642-644. PubMed ID: 33257642 [TBL] [Abstract][Full Text] [Related]
10. Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased? Takahashi S; Greenhouse B; Rodríguez-Barraquer I J Infect Dis; 2020 Nov; 222(11):1772-1775. PubMed ID: 32856712 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Panbio COVID-19 Rapid Antigen Detection Test Device for the Screening of Patients with COVID-19. Fenollar F; Bouam A; Ballouche M; Fuster L; Prudent E; Colson P; Tissot-Dupont H; Million M; Drancourt M; Raoult D; Fournier PE J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139420 [No Abstract] [Full Text] [Related]
12. Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests. Wakita M; Idei M; Saito K; Horiuchi Y; Yamatani K; Ishikawa S; Yamamoto T; Igawa G; Hinata M; Kadota K; Kurosawa T; Takahashi S; Saito T; Misawa S; Akazawa C; Naito T; Miida T; Takahashi K; Ai T; Tabe Y PLoS One; 2021; 16(2):e0246536. PubMed ID: 33556086 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of six anti-SARS-CoV-2 antibody test kits and practical approaches to optimize the diagnostic performance. Ko JH; Joo EJ; Baek JY; Huh K; Cho SY; Kang CI; Chung DR; Kim YJ; Kang ES; Peck KR J Microbiol Immunol Infect; 2021 Oct; 54(5):983-986. PubMed ID: 33836943 [TBL] [Abstract][Full Text] [Related]
14. Analytical sensitivity and clinical sensitivity of the three rapid antigen detection kits for detection of SARS-CoV-2 virus. Mak GC; Lau SS; Wong KK; Chow NL; Lau CS; Lam ET; Chan RC; Tsang DN J Clin Virol; 2020 Dec; 133():104684. PubMed ID: 33176236 [TBL] [Abstract][Full Text] [Related]
15. Coronavirus disease 2019 antibody testing in pregnancy. Zullo F; Di Mascio D; Saccone G Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100142. PubMed ID: 32427172 [No Abstract] [Full Text] [Related]
16. Comparative analysis of three laboratory based serological assays for SARS-CoV-2 in an Australian cohort. Davidson N; Evans J; Giammichele D; Powell H; Hobson P; Teis B; Glover H; Guppy-Coles KB; Robson J Pathology; 2020 Dec; 52(7):764-769. PubMed ID: 33070955 [TBL] [Abstract][Full Text] [Related]
17. Evaluating the newly developed BioFire COVID-19 test for SARS-CoV-2 molecular detection. Liotti FM; Menchinelli G; Marchetti S; Morandotti GA; Sanguinetti M; Posteraro B; Cattani P Clin Microbiol Infect; 2020 Dec; 26(12):1699-1700. PubMed ID: 32735938 [No Abstract] [Full Text] [Related]
18. Rapid coronavirus tests: a guide for the perplexed. Guglielmi G Nature; 2021 Feb; 590(7845):202-205. PubMed ID: 33564189 [No Abstract] [Full Text] [Related]
19. Greater public health impact of COVID-19 antigen detection tests. Kowada A BMC Med; 2021 Mar; 19(1):82. PubMed ID: 33757504 [No Abstract] [Full Text] [Related]
20. Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting. Osterman A; Baldauf HM; Eletreby M; Wettengel JM; Afridi SQ; Fuchs T; Holzmann E; Maier A; Döring J; Grzimek-Koschewa N; Muenchhoff M; Protzer U; Kaderali L; Keppler OT Med Microbiol Immunol; 2021 Feb; 210(1):65-72. PubMed ID: 33452927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]